140 related articles for article (PubMed ID: 14564191)
1. Transradial approach for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: comparison with conventional transfemoral approach.
Shiozawa S; Tsuchiya A; Endo S; Kato H; Katsube T; Kumazawa K; Naritaka Y; Ogawa K
J Clin Gastroenterol; 2003; 37(5):412-7. PubMed ID: 14564191
[TBL] [Abstract][Full Text] [Related]
2. Transradial arterial chemoembolization reduces complications and costs in patients with hepatocellular carcinoma.
Wu T; Sun R; Huang Y; Wang Z; Yin X; Zhu Z; Zhao Z; He J
Indian J Cancer; 2015 Dec; 52 Suppl 2():e107-11. PubMed ID: 26728666
[TBL] [Abstract][Full Text] [Related]
3. [Transradial approach for transcatheter arterial chemoembolization in patients with unresectable and recurrent hepatocellular carcinoma--a comparison with a conventional transfemoral approach].
Shiozawa S; Tsuchiya A; Kim DH; Usui T; Inose S; Aizawa M; Masuda T; Yoshimatsu K; Katsube T; Naritaka Y; Ogawa K
Gan To Kagaku Ryoho; 2007 Nov; 34(12):2096-8. PubMed ID: 18219910
[TBL] [Abstract][Full Text] [Related]
4. [Transradial approach for transcatheter arterial chemoembolization in patients with hepatocellular carcinoma].
Shiozawa S; Tsuchiya A; Endo S; Kumazawa K; Ogawa K
Nihon Shokakibyo Gakkai Zasshi; 2002 Dec; 99(12):1450-4. PubMed ID: 12518393
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
Sahara S; Kawai N; Sato M; Tanaka T; Ikoma A; Nakata K; Sanda H; Minamiguchi H; Nakai M; Shirai S; Sonomura T
Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1363-71. PubMed ID: 22358993
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
Lu W; Li Y; He X; Chen Y
Hepatogastroenterology; 2003; 50(54):2079-83. PubMed ID: 14696468
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of bile duct injury after transcatheter arterial chemoembolization].
Wang MQ; Shao RH; Ye HY; Wang ZQ; Wang ZP; Liu FY
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):609-12. PubMed ID: 16438871
[TBL] [Abstract][Full Text] [Related]
8. Comparison of local control effects of superselective transcatheter arterial chemoembolization using epirubicin plus mitomycin C and miriplatin for hepatocellular carcinoma.
Miyayama S; Yamashiro M; Shibata Y; Hashimoto M; Yoshida M; Tsuji K; Toshima F; Matsui O
Jpn J Radiol; 2012 Apr; 30(3):263-70. PubMed ID: 22223074
[TBL] [Abstract][Full Text] [Related]
9. Transfemoral approach using a 3.5-French catheter system for use in transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: technical assessment.
Ohuchi Y; Kaminou T; Hashimoto M; Sugiura K; Adachi A; Kawai T; Endou M; Ogawa T
Hepatogastroenterology; 2011; 58(107-108):916-21. PubMed ID: 21830416
[TBL] [Abstract][Full Text] [Related]
10. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
[TBL] [Abstract][Full Text] [Related]
11. Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma.
Lin CI; Lin ZY; Hsieh MY; Huang CF; Chen SH; Chuang WL
Kaohsiung J Med Sci; 2011 Dec; 27(12):554-9. PubMed ID: 22208538
[TBL] [Abstract][Full Text] [Related]
12. [External radiation and combined transcatheter arterial chemoembolization for unresectable primary liver cancer].
Liu MZ; Wang XS; Cai L; Gu MF; Liu H; Li Q; Cui NJ; Zhang YQ; Li GH; Li JQ
Ai Zheng; 2005 Jan; 24(1):82-6. PubMed ID: 15642207
[TBL] [Abstract][Full Text] [Related]
13. Balloon-Occluded Transcatheter Arterial Chemoembolization (b-TACE) for Hepatocellular Carcinoma Performed with Polyethylene-Glycol Epirubicin-Loaded Drug-Eluting Embolics: Safety and Preliminary Results.
Lucatelli P; Ginnani Corradini L; De Rubeis G; Rocco B; Basilico F; Cannavale A; Nardis PG; Corona M; Saba L; Catalano C; Bezzi M
Cardiovasc Intervent Radiol; 2019 Jun; 42(6):853-862. PubMed ID: 30843093
[TBL] [Abstract][Full Text] [Related]
14. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma.
Nishikawa H; Osaki Y; Kita R; Kimura T; Ohara Y; Takeda H; Sakamoto A; Saito S; Nishijima N; Nasu A; Komekado H; Nishiguchi S
Oncol Rep; 2014 Jan; 31(1):65-72. PubMed ID: 24220763
[TBL] [Abstract][Full Text] [Related]
15. Study on the changes in microvessel density in hepatocellular carcinoma following transcatheter arterial chemoembolization.
Yi J; Liao X; Yang Z; Li X
J Tongji Med Univ; 2001; 21(4):321-2, 331. PubMed ID: 12539559
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the relationship between hepatocellular carcinoma location and transarterial chemoembolization efficacy.
Miki I; Murata S; Uchiyama F; Yasui D; Ueda T; Sugihara F; Saito H; Yamaguchi H; Murakami R; Kawamoto C; Uchida E; Kumita SI
World J Gastroenterol; 2017 Sep; 23(35):6437-6447. PubMed ID: 29085193
[TBL] [Abstract][Full Text] [Related]
17. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
[TBL] [Abstract][Full Text] [Related]
18. Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization.
Lu W; Li YH; He XF; Zhao JB; Chen Y; Mei QL
Cardiovasc Intervent Radiol; 2008; 31(6):1133-40. PubMed ID: 18584240
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma.
Lu W; Li YH; Yu ZJ; He XF; Chen Y; Zhao JB; Zhu ZY
Hepatogastroenterology; 2007; 54(77):1499-502. PubMed ID: 17708284
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular carcinoma associated with Budd-Chiari syndrome: imaging features and transcatheter arterial chemoembolization.
Liu FY; Wang MQ; Duan F; Fan QS; Song P; Wang Y
BMC Gastroenterol; 2013 Jun; 13():105. PubMed ID: 23800233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
